Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Arch Oral Biol ; 143: 105520, 2022 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-36049430

RESUMO

OBJECTIVE: This study aimed to evaluate the antibacterial activity of crude Brazilian red propolis (BRP) extract against anaerobic bacteria involved in primary endodontic infection. Additionally, we evaluate the cell viability and free radical production of human dental pulp fibroblasts (HDPF) in direct contact with mineral trioxide aggregate (MTA) and BRP. DESIGN: The Minimum Inhibitory Concentration, Minimum Bactericidal Concentration (MIC, MBC) and Minimum Inhibitory Concentration of Biofilm (MICB50) of BRP against anaerobic endodontic pathogens were determined. HDPF were exposed to BRP10 (10 µg/mL), BRP50 (50 µg/mL), MTA extract (1:1, 1:2, 1:4 e 1:8), dimethyl sulfoxide 0.5% (DMSO), and cell culture medium (DMEM). The groups were tested for cell viability (MTT assay), and free radical production (reactive oxygen species - ROS, DCFH-DA probe and nitric oxide - NO, Griess reagent). The one-way ANOVA and Tukey's tests were employed at a significance level of 5%. RESULTS: MIC/MBC values of BRP performed antibacterial activity for Parvimonas micra (6.25/6.25 µg/mL), Fusobacterium nucleatum (25/25 µg/mL), Prevotella melaninogenica (50/100 µg/mL), Prevotella nigrescens (50/100 µg/mL), Prevotella intermedia (50/100 µg/mL), and Porphyromonas gingivalis (50/200 µg/mL). The MICB50 values ranged from 1.56 to 50 µg/mL. BRP and MTA stimulated cell viability, emphasizing BRP10 (p = 0.007). Furthermore, it was observed that MTA 1:1, MTA 1:2, and BRP50 slightly increased ROS (p < 0.001) and NO production (p = 0.008, p = 0.007, and p < 0.001 respectively) compared to DMEM group. CONCLUSIONS: BRP exhibits good antibacterial activity against endodontic pathogens, and both BRP and MTA promote the viability of HDPF without increasing NO and ROS production.


Assuntos
Própole , Humanos , Antibacterianos/farmacologia , Brasil , Dimetil Sulfóxido , Testes de Sensibilidade Microbiana , Óxido Nítrico , Extratos Vegetais/farmacologia , Própole/farmacologia , Espécies Reativas de Oxigênio
2.
Sci Rep ; 10(1): 15158, 2020 09 16.
Artigo em Inglês | MEDLINE | ID: mdl-32938966

RESUMO

The combination of pyrimethamine and sulfadiazine is the standard care in cases of congenital toxoplasmosis. However, therapy with these drugs is associated with severe and sometimes life-threatening side effects. The investigation of phytotherapeutic alternatives to treat parasitic diseases without acute toxicity is essential for the advancement of current therapeutic practices. The present study investigates the antiparasitic effects of oleoresins from different species of Copaifera genus against T. gondii. Oleoresins from C. reticulata, C. duckei, C. paupera, and C. pubiflora were used to treat human trophoblastic cells (BeWo cells) and human villous explants infected with T. gondii. Our results demonstrated that oleoresins were able to reduce T. gondii intracellular proliferation, adhesion, and invasion. We observed an irreversible concentration-dependent antiparasitic action in infected BeWo cells, as well as parasite cell cycle arrest in the S/M phase. The oleoresins altered the host cell environment by modulation of ROS, IL-6, and MIF production in BeWo cells. Also, Copaifera oleoresins reduced parasite replication and TNF-α release in villous explants. Anti-T. gondii effects triggered by the oleoresins are associated with immunomodulation of the host cells, as well as, direct action on parasites.


Assuntos
Antiprotozoários/farmacologia , Fabaceae/química , Extratos Vegetais/farmacologia , Complicações Parasitárias na Gravidez/tratamento farmacológico , Toxoplasmose/complicações , Toxoplasmose/tratamento farmacológico , Animais , Antiprotozoários/administração & dosagem , Antiprotozoários/isolamento & purificação , Pontos de Checagem do Ciclo Celular/efeitos dos fármacos , Linhagem Celular , Citocinas/metabolismo , Relação Dose-Resposta a Droga , Fabaceae/classificação , Feminino , Interações Hospedeiro-Parasita/efeitos dos fármacos , Humanos , Microscopia Eletrônica de Transmissão , Fitoterapia , Placenta/efeitos dos fármacos , Placenta/parasitologia , Extratos Vegetais/administração & dosagem , Extratos Vegetais/isolamento & purificação , Gravidez , Complicações Parasitárias na Gravidez/parasitologia , Espécies Reativas de Oxigênio/metabolismo , Toxoplasma/citologia , Toxoplasma/efeitos dos fármacos , Toxoplasma/patogenicidade , Toxoplasmose/parasitologia , Trofoblastos/efeitos dos fármacos , Trofoblastos/parasitologia
3.
Nano Lett ; 14(9): 5452-7, 2014 Sep 10.
Artigo em Inglês | MEDLINE | ID: mdl-25162369

RESUMO

Quantum dots are potentially very useful as fluorescent probes in biological systems. However, they are inherently cytotoxic because of their constituents. We controlled the cytotoxicity of CdSe magic-sized quantum dots (MSQDs) as a function of surface defect density by altering selenium (Se) concentration during synthesis. Higher Se concentrations reduced the cytotoxicity of the CdSe MSQDs and diminished mRNA expression of methallothionein because of the low cadmium ions (Cd(2+)) concentration adsorbed on the surface of the MSQDs. These results agree with luminescence spectra, which show that higher Se concentrations decrease the density of surface defects. Therefore, our results describe for the first time a simple way of controlling the cytotoxicity of CdSe MSQDs and making them safer to use as fluorescence probes in biological systems.


Assuntos
Compostos de Cádmio/química , Metalotioneína/química , Nanotecnologia/métodos , Pontos Quânticos , Compostos de Selênio/química , Actinas/química , Cádmio/química , Células HeLa , Humanos , Íons , Luminescência , Estresse Oxidativo , Espécies Reativas de Oxigênio , Selênio/química , Propriedades de Superfície , Temperatura
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA